How Should We Determine the Value of CAR T-Cell Therapy?

AMA journal of ethics - United States
doi 10.1001/amajethics.2019.844
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

American Medical Association (AMA)

Related search

A Bump in the Road: How the Hostile AML Microenvironment Affects CAR T Cell Therapy

Frontiers in Oncology
Cancer ResearchOncology
2020English

Next Frontiers in CAR T-Cell Therapy

Molecular Therapy - Oncolytics
Cancer ResearchOncologyMolecular MedicinePharmacology
2016English

CAR T-Cell Therapy for Solid Tumors?

Cancer Discovery
Oncology
2018English

Teaming Up for CAR-T Cell Therapy

Haematologica
Hematology
2019English

How We Should Measure "Change": Or Should We?

Psychological Bulletin
Philosophy of SciencePsychologyHistory
1970English

The Future: In Vivo CAR T Cell Gene Therapy

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2019English

Resisting CAR T-Cell Therapy: A Case Study

Cancer Discovery
Oncology
2018English

How Should We Estimate Value-Relevance Models? Insights From European Data

British Accounting Review
Accounting
2017English

How Should We Value Future Health? Was NICE Right to Change?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy